Newborn Screening for Cystic Fibrosis Less Accurate in Minorities

MONDAY, Oct. 31, 2022 -- Cystic fibrosis transmembrane conductance regulator (CFTR) variant panels have lower detection rates when used for newborn screening (NBS) in racial and ethnic-minority groups, according to a study published online Oct. 13...